We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$453M
AUM Growth
+$35M
Cap. Flow
+$5.79M
Cap. Flow %
1.28%
Top 10 Hldgs %
30.05%
Holding
121
New
5
Increased
36
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$2.66M
2
INDB icon
Independent Bank
INDB
+$1.16M
3
PG icon
Procter & Gamble
PG
+$715K
4
ADBE icon
Adobe
ADBE
+$284K
5
AMZN icon
Amazon
AMZN
+$218K

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Healthcare 11.25%
3 Financials 10.68%
4 Consumer Staples 10.68%
5 Industrials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$642B
$6.34M 1.4%
56,221
+1,447
+3% +$161K
IEFA icon
27
iShares Core MSCI EAFE ETF
IEFA
$191B
$6.16M 1.36%
70,577
+31
+0% +$2.63K
LMT icon
28
Lockheed Martin
LMT
$136B
$5.84M 1.29%
11,692
+188
+2% +$85.3K
GIS icon
29
General Mills
GIS
$19.4B
$5.82M 1.28%
115,357
+1,871
+2% +$93.8K
NEE icon
30
NextEra Energy
NEE
$181B
$5.81M 1.28%
77,021
+98
+0.1% +$7.16K
MRK icon
31
Merck
MRK
$316B
$5.67M 1.25%
67,615
+256
+0.4% +$21.1K
SYY icon
32
Sysco
SYY
$40.9B
$5.66M 1.25%
68,737
+532
+0.8% +$42.5K
DUK icon
33
Duke Energy
DUK
$97.7B
$5.63M 1.24%
45,537
-118
-0.3% -$14.3K
DIS icon
34
Walt Disney
DIS
$170B
$5.42M 1.2%
47,360
+880
+2% +$104K
TMO icon
35
Thermo Fisher Scientific
TMO
$216B
$5.32M 1.17%
10,971
+17
+0.2% +$7.91K
KO icon
36
Coca-Cola
KO
$375B
$5.16M 1.14%
77,743
+2,008
+3% +$138K
CL icon
37
Colgate-Palmolive
CL
$73.6B
$5.11M 1.13%
63,926
+986
+2% +$84.1K
IWM icon
38
iShares Russell 2000 ETF
IWM
$81.4B
$5.08M 1.12%
20,975
PEP icon
39
PepsiCo
PEP
$191B
$5.05M 1.11%
35,981
-469
-1% -$67K
ACN icon
40
Accenture
ACN
$102B
$4.9M 1.08%
19,854
+798
+4% +$208K
MDT icon
41
Medtronic
MDT
$111B
$4.84M 1.07%
50,778
+281
+0.6% +$25.8K
USB icon
42
US Bancorp
USB
$99.3B
$4.78M 1.05%
98,833
+794
+0.8% +$37.6K
VZ icon
43
Verizon
VZ
$199B
$4.78M 1.05%
108,650
+689
+0.6% +$29.8K
SPY icon
44
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$4.69M 1.04%
7,046
-49
-0.7% -$31.4K
ADBE icon
45
Adobe
ADBE
$101B
$4.47M 0.99%
12,668
+792
+7% +$284K
CMCSA icon
46
Comcast
CMCSA
$87.3B
$4.39M 0.97%
139,866
+2,851
+2% +$95.6K
CTAS icon
47
Cintas
CTAS
$82B
$4.16M 0.92%
20,270
VTI icon
48
Vanguard Morningstar Total Stock Market ETF
VTI
$668B
$4.06M 0.9%
12,380
OMC icon
49
Omnicom Group
OMC
$22.1B
$4.05M 0.89%
49,661
-600
-1% -$45.3K
XLE icon
50
State Street Energy Select Sector SPDR ETF
XLE
$38.6B
$3.81M 0.84%
85,392
-2,568
-3% -$112K

Similar funds

Boston Research & Management's Q3 2025 Portfolio in Review

As of Q3 2025, Boston Research & Management held 121 positions worth $453M, up 8.4% from $418M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Boston Research & Management's Q3 2025 filing shows 5 new, 36 increased, 29 reduced and 2 closed positions. Its largest new stake was Equinix: 3,402 shares worth $2.66M. The largest sale was Bank of New York Mellon, an estimated $228K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Boston Research & Management's largest Q3 2025 buy was Equinix: 3,402 shares worth $2.66M.
  • Boston Research & Management added most to Procter & Gamble in Q3 2025, an estimated $715K increase.
  • Boston Research & Management's biggest Q3 2025 reduction was Bank of New York Mellon, cutting an estimated $228K.
  • Boston Research & Management fully exited Worthington Enterprises in Q3 2025, selling an estimated $222K.
  • Boston Research & Management's ten largest holdings make up 30% of its $453M portfolio in Q3 2025.
  • Boston Research & Management opened 5 new positions and closed 2 in Q3 2025.
  • Boston Research & Management's portfolio value rose 8.4% quarter-over-quarter to $453M.

Based on Boston Research & Management's 13F filing for Q3 2025, filed 12 Nov 2025.